Publication:
Free Text: A phenotypic mouse model of basaloid breast tumors.


abstract

Chemotherapeutic strategies that target basal-like breast tumors are difficult to design without understanding their cellular and molecular basis. Here, we induce tumors in mice by carcinogen administration, creating a phenocopy of tumors with the diagnostic and functional aspects of human triple negative disease (including EGFR expression/lack of erbB, estrogen-independent growth and co-clustering of the transcriptome with other basaloid models). These tumor strains are a complement to established mouse models that are based on mutations in Brca1 and/or p53. Tumors comprise two distinct cell subpopulations, basal and luminal epithelial cells. These cell fractions were purified by flow cytometry, and only basal cell fractions found to have tumor initiating activity (cancer stem cells). The phenotype of serially regenerated tumors was stable, and irrespective of tumor precursor cell. Tumors were passaged entirely in vivo and serial generations tested for their phenotypic stability. The relative chemo-sensitivity of basal and luminal cells were evaluated. Upon treatment with anthracycline, tumors were effectively de-bulked, but recurred; this correlated with maintenance of a high rate of basal cell division throughout the treatment period. Thus, these tumors grow as robust cell mixtures of basal bipotential tumor initiating cells alongside a luminal majority, and the cellular response to drug administration is dominated by the distinct biology of the two cell types. Given the ability to separate basal and luminal cells, and the discovery potential of this approach, we propose that this mouse model could be a convenient one for preclinical studies.

Related Articles
Final Report on Carcinogens Background Document for Styrene.
Rep Carcinog Backgr Doc. 2008
Final Report on Carcinogens Background Document for Styrene.
National Toxicology Program. Rep Carcinog Backgr Doc. 2008 Sep; (8-5978):i-398.
Final Report on Carcinogens Background Document for Formaldehyde.
Rep Carcinog Backgr Doc. 2010
Final Report on Carcinogens Background Document for Formaldehyde.
National Toxicology Program. Rep Carcinog Backgr Doc. 2010 Jan; (10-5981):i-512.
Differentiation generates paracrine cell pairs that maintain basaloid mouse mammary tumors: proof of concept.
PLoS One. 2011
Differentiation generates paracrine cell pairs that maintain basaloid mouse mammary tumors: proof of concept.
Kim S, Goel S, Alexander CM. PLoS One. 2011 Apr 26; 6(4):e19310. Epub 2011 Apr 26.
Review The cell of origin of BRCA1 mutation-associated breast cancer: a cautionary tale of gene expression profiling.
J Mammary Gland Biol Neoplasia...
Review The cell of origin of BRCA1 mutation-associated breast cancer: a cautionary tale of gene expression profiling.
Molyneux G, Smalley MJ. J Mammary Gland Biol Neoplasia. 2011 Apr; 16(1):51-5. Epub 2011 Feb 19.
Review Transforming growth factor-beta signaling: emerging stem cell target in metastatic breast cancer?
Breast Cancer Res Treat. 2009
Review Transforming growth factor-beta signaling: emerging stem cell target in metastatic breast cancer?
Tan AR, Alexe G, Reiss M. Breast Cancer Res Treat. 2009 Jun; 115(3):453-95. Epub 2008 Oct 9.